MaxCyte to Participate in Three Upcoming Investor Conferences
ROCKVILLE, Md., Oct. 28, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (NASDAQ: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell therapeutics, today announced Company management will participate in three upcoming investor conferences.
Covered in this story
Call it yourself
No calls on $MXCT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Maxcyte Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.